Q1 2026 Holdings
Filed 2026-05-15 | 54 holdings | $761.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $227.5M | 10,876,219 | 29.9% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $51.9M | 1,361,000 | 6.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $48.6M | 500,000 | 6.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $27.4M | 329,100 | 3.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $25.7M | 225,000 | 3.4% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $22.3M | 766,318 | 2.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $22.3M | 200,000 | 2.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $19.8M | 375,000 | 2.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $18.9M | 325,000 | 2.5% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $17.9M | 590,000 | 2.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $17.9M | 170,000 | 2.4% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $16.7M | 1,866,000 | 2.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $16.1M | 1,100,000 | 2.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $15.0M | 46,457 | 2.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $13.6M | 200,000 | 1.8% |
| Precigen Inc(PGEN) | COM | 74017N105 | $13.5M | 3,500,000 | 1.8% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $11.3M | 598,500 | 1.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $11.1M | 800,000 | 1.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $10.8M | 662,000 | 1.4% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $10.2M | 2,250,000 | 1.3% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $10.1M | 250,000 | 1.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $9.0M | 500,000 | 1.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $9.0M | 1,175,000 | 1.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.7M | 225,000 | 1.1% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $8.4M | 4,799,875 | 1.1% |
| Crescent Biopharma Inc. | COM | 38000Q201 | $8.3M | 453,686 | 1.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.7M | 200,000 | 0.9% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $6.6M | 2,725,000 | 0.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.6M | 100,000 | 0.9% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $6.5M | 494,000 | 0.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $5.9M | 70,000 | 0.8% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.9M | 842,106 | 0.8% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $5.4M | 900,000 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $5.1M | 275,000 | 0.7% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $4.5M | 300,000 | 0.6% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $4.1M | 2,370,122 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.6M | 75,000 | 0.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.3M | 150,000 | 0.4% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $3.1M | 640,000 | 0.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.0M | 350,000 | 0.4% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $2.6M | 749,035 | 0.3% |
| Clene Inc(CLNN) | COM NEW | 185634201 | $2.4M | 477,515 | 0.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.2M | 176,500 | 0.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.2M | 300,000 | 0.3% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.0M | 1,500,000 | 0.3% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $1.7M | 70,000 | 0.2% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $1.7M | 302,536 | 0.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $1.6M | 100,000 | 0.2% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $1.4M | 150,000 | 0.2% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $793.3K | 666,666 | 0.1% |